Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MECHELEN, Belgium, March 7, 2014 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announced today the receipt of €2 million for a partial milestone in the osteoarthritis alliance with...
-
MECHELEN, Belgium, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announced today that it has been awarded a €2.3 million grant for research in fibrosis from the Flemish agency...
-
MECHELEN, Belgium, Jan. 13, 2014 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announced today that it has been awarded a €2.9 million grant from the Flemish agency for Innovation by Science...
-
MECHELEN, Belgium, Oct. 16, 2013 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announced today that the Company will present in vitro and Phase 1 data showing potent and selective inhibition of...
-
GLPG1205 is a first-in-class molecule to enter the clinic Candidate drug targets inflammation of the bowel Galapagos receives €6.6 million milestone payment Mechelen, Belgium; 2 July 2013 -...
-
GLPG1205 is 'first-in-class' molecuul dat de kliniek ingaat Kandidaat-medicijn voor behandeling van darmontsteking Galapagos ontvangt €6,6 miljoen succesbetaling Mechelen, België; 2 juli...
-
Mechelen, België; 16 januari 2012 - Galapagos NV (Euronext: GLPG) kondigt aan dat zij een tweede kandidaat-medicijn heeft geïdentificeerd binnen de overeenkomst met Janssen Pharmaceutica NV. Het...
-
Mechelen, Belgium; 16 January 2012 - Galapagos NV (Euronext: GLPG) announced today that it has identified a second pre-clinical compound in its alliance with Janssen Pharmaceutica NV. This...
-
Mechelen, België; 18 mei 2012 - Galapagos NV (Euronext: GLPG) kondigt vandaag aan dat zij op grond van de operationele en financiële resultaten die tot dusver in 2012 zijn behaald, de eerder...
-
Mechelen, Belgium; 18 May 2012 - Galapagos NV (Euronext: GLPG) announces today that the operational and financial results achieved thus far in 2012 encourage the Company to retain full year 2012...